Mood Disorders Program, Department of Psychiatry, University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA.
School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.
Medicina (Kaunas). 2024 Jun 3;60(6):936. doi: 10.3390/medicina60060936.
: Options for treatment-resistant bipolar depression (TRBPD) are limited. Electroconvulsive therapy (ECT) has shown efficacy in TRBPD. However, the cognitive deficits and memory concerns associated with ECT are problematic for a significant number of patients. It remains unclear what the next step is for patients with TRBPD who fail ECT. In this case report, we present a patient with TRBPD who sequentially received 12 sessions of brief-pulse right unilateral ECT, 22 sessions of ketamine infusion at 0.5-0.75 mg/kg for 40 min, and 39 sessions of deep repetitive transcranial magnetic stimulation (dTMS). The patient had some benefit from ECT, but declined continuation of ECT due to memory concerns. The patient tolerated ketamine infusion well but had limited benefit. However, the patient responded well to acute treatment with dTMS and maintained relative stability for more than 2 years. This case suggests that patients with TRBPD who fail ECT and/or ketamine infusion might benefit from dTMS.
治疗抵抗性双相抑郁(TRBPD)的治疗选择有限。电惊厥疗法(ECT)已被证明对 TRBPD 有效。然而,ECT 相关的认知缺陷和记忆问题对相当数量的患者来说是个问题。对于 ECT 治疗失败的 TRBPD 患者,下一步该怎么做仍不清楚。在本病例报告中,我们介绍了一位 TRBPD 患者,他先后接受了 12 次短脉冲右单侧 ECT、22 次 0.5-0.75mg/kg 持续 40 分钟的氯胺酮输注和 39 次深部重复经颅磁刺激(dTMS)。该患者从 ECT 中获益,但因记忆问题拒绝继续 ECT。患者对氯胺酮输注耐受良好,但获益有限。然而,患者对 dTMS 的急性治疗反应良好,并在 2 年多的时间里保持相对稳定。本病例提示,ECT 和/或氯胺酮输注治疗失败的 TRBPD 患者可能从 dTMS 中获益。